In vitro antibacterial activity evaluations and AFM observations of chitosan/hydroxyapatite-gentamicin as drug delivery system
Source abstract
Abstract
Chitosan/Hydroxyapatite-gentamicin(CS/HA-G) was prepared as a drug delivery system(DDS) for the treatment of osteomyelitis and its antibacterial activity was evaluated by treating with E coli,the ultrastructure of E coli after treatment were observed by an AFM.Gentamicin was loaded on CS/HA in different CS:HA ratios and this DDS had been tested for its vitro release ratio and antibacterial activity against Escherichia coli.The result showed that gentamicin could effectively release from CS/HA-G for more than 30days.AFM ultrastructure images indicated the height and Ra(average roughness) of Escherichia coli cells all decreased.CS/HA can be used as an ideal gentamicin carrier and has great potential in E.coli osteomyelitis therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Antimicrobial agents and applications · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.